Baclofen for Improving Benzodiazepine Titration in Benzodiazepine Dependence

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2027

Conditions
Benzodiazepine Dependence
Interventions
DRUG

Baclofen 30 mg

"* baclofen 10 mg capsule (for the 30 mg-baclofen 30 mg arm)~* Dosage: 3 capsules of baclofen 10 mg per day~* route of administration: Oral~* duration of treatment: Total duration of treatment is 13 weeks including 1 week of dose escalation, 11 weeks of maintenance at full dose, and 1 week of dose de-escalation"

DRUG

Baclofen 60 mg

"* baclofen 20 mg capsule (for the 60 mg baclofen arm)~* Dosage: 3 capsules of baclofen 20 mg per day~* route of administration: Oral~* duration of treatment: Total duration of treatment is 13 weeks including 1 week of dose escalation, 11 weeks of maintenance at full dose, and 1 week of dose de-escalation"

DRUG

Placebo

"* placebo capsule (for the placebo arm)~* Dosage:3 capsules of placebo per day~* route of administration: Oral~* duration of treatment: Total duration of treatment is 13 weeks including 1 week of dose escalation, 11 weeks of maintenance at full dose, and 1 week of dose de-escalation"

Trial Locations (2)

69003

Hôpital Edouard Herriot, Lyon

69500

Centre Hospitalier le Vinatier, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT05935553 - Baclofen for Improving Benzodiazepine Titration in Benzodiazepine Dependence | Biotech Hunter | Biotech Hunter